Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Axovant, Benetic jump on agreement to develop gene therapy for MD
By Alexander Nicoll
Jul 9, 2018 11:04 AM EDT
PRESS RELEASES
Axon And Cellebrite Partner To Help Manage And Safeguard Digital Intelligence
By PR Newswire
Feb 9, 2021 7:30 AM EST
PRESS RELEASES
Axon And Cellebrite Partner To Help Manage And Safeguard Digital Intelligence
By PR Newswire
Feb 9, 2021 7:30 AM EST
STOCKS
Axovant, Benetic jump on agreement to develop gene therapy for MD
By Alexander Nicoll
Jul 9, 2018 11:04 AM EDT
JIM CRAMER
Okta, Celgene, Altria: 'Mad Money' Lightning Round
By Scott Rutt
Jun 16, 2018 6:45 AM EDT
JIM CRAMER
Tread Carefully: Cramer's 'Mad Money' Recap
By Scott Rutt
Jun 16, 2018 6:40 AM EDT
INVESTING
These Stocks Are Leading the Nasdaq's Record-Setting Push
By Tony Owusu
Jun 7, 2018 10:30 AM EDT
MARKETS
Stocks Rip Higher, Dow Jumps Over 400 Points as Markets Rebound
By Joseph Woelfel
Feb 12, 2018 4:15 PM EST
STOCKS
Axovant shares crater as CEO and President both resign
By Armie Margaret Lee
Feb 12, 2018 10:18 AM EST
JIM CRAMER
Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
By Scott Rutt
Jan 17, 2018 6:10 AM EST
MERGERS AND ACQUISITIONS
Where Softbank Founder Masayoshi Son Is Placing Big Bets
By Chris Nolter
Dec 2, 2017 1:07 PM EST
STOCKS
Axovant Rises After Tuesday's Plunge - Biotech Movers
By Armie Margaret Lee
Sep 27, 2017 9:46 AM EDT
STOCKS
Axovant Plummets On Disappointing Alzheimer's Treatment Data - Biotech Movers
By Armie Margaret Lee
Sep 26, 2017 4:26 PM EDT
VIDEO
Stocks Largely Hold on to Gains Following Yellen's Speech
By Anders Keitz
Sep 26, 2017 4:21 PM EDT
FUTURES
Stocks Rise as Fed's Yellen Walks the Line on Future Rate Hikes
By Keris Alison Lahiff
Sep 26, 2017 2:08 PM EDT
HEALTH
Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks
By Armie Margaret Lee
Jul 14, 2017 4:11 PM EDT
HEALTH
Biotech Movers: OncoMed Tanks After Barrage of Bad News, Geron Spikes on New Data
By Armie Margaret Lee
Apr 10, 2017 1:50 PM EDT
STOCKS
Medivation Founder Takes Helm at Axovant, Shares Spike
By Alicia McElhaney
Apr 10, 2017 10:00 AM EDT
STOCKS
Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk
By Adam Feuerstein
Mar 24, 2017 8:34 AM EDT
STOCKS
17 thoughts on biotech stocks to kick off 2017
By Adam Feuerstein
Jan 3, 2017 6:35 AM EST
MARKETS
Axovant Sciences (AXON) Stock Slumps, Baird: Weakness 'Unwarranted'
By Rachel Aldrich
Sep 22, 2016 2:12 PM EDT
STOCKS
Axovant sinks on rival's Alzheimer's drug setback
By Adam Feuerstein
Sep 22, 2016 12:32 PM EDT
OPINION
Acadia drug approval may entice biogen, teva as buyers
By Alicia McElhaney
May 5, 2016 3:22 PM EDT
STOCKS
Why the failure of a Pfizer drug is sinking Axovant
By Adam Feuerstein
Feb 2, 2016 10:17 AM EST
STOCKS
Editas' IPO challenge: edit investor expectations as well as diseased genes
By Adam Feuerstein
Jan 5, 2016 8:27 AM EST
